Diagnostic Performance of Conventional and Ultrasensitive Rapid Diagnostic Tests for Malaria in Febrile Outpatients in Tanzania.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
16 04 2019
Historique:
received: 05 10 2018
accepted: 21 11 2018
pubmed: 27 11 2018
medline: 10 1 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

A novel ultrasensitive malaria rapid diagnostic test (us-RDT) has been developed for improved active Plasmodium falciparum infection detection. The usefulness of this us-RDT in clinical diagnosis and fever management has not been evaluated. Diagnostic performance of us-RDT was compared retrospectively to that of conventional RDT (co-RDT) in 3000 children and 515 adults presenting with fever to Tanzanian outpatient clinics. The parasite density was measured by an ultrasensitive qPCR (us-qPCR), and the HRP2 concentration was measured by an enzyme-linked immunosorbent assay. us-RDT identified few additional P. falciparum-positive patients as compared to co-RDT (276 vs 265 parasite-positive patients detected), with only a marginally greater sensitivity (75% vs 73%), using us-qPCR as the gold standard (357 parasite-positive patients detected). The specificity of both RDTs was >99%. Five of 11 additional patients testing positive by us-RDT had negative results by us-qPCR. The HRP2 concentration was above the limit of detection for co-RDT (>3653 pg of HRP2 per mL of blood) in almost all infections (99% [236 of 239]) with a parasite density >100 parasites per µL of blood. At parasite densities <100 parasites/µL, the HRP2 concentration was above the limits of detection of us-RDT (>793 pg/mL) and co-RDT in 29 (25%) and 24 (20%) of 118 patients, respectively. There is neither an advantage nor a risk of using us-RDT, rather than co-RDT, for clinical malaria diagnosis. In febrile patients, only a small proportion of infections are characterized by a parasite density or an HRP2 concentration in the range where use of us-RDT would confer a meaningful advantage over co-RDT.

Sections du résumé

BACKGROUND
A novel ultrasensitive malaria rapid diagnostic test (us-RDT) has been developed for improved active Plasmodium falciparum infection detection. The usefulness of this us-RDT in clinical diagnosis and fever management has not been evaluated.
METHODS
Diagnostic performance of us-RDT was compared retrospectively to that of conventional RDT (co-RDT) in 3000 children and 515 adults presenting with fever to Tanzanian outpatient clinics. The parasite density was measured by an ultrasensitive qPCR (us-qPCR), and the HRP2 concentration was measured by an enzyme-linked immunosorbent assay.
RESULTS
us-RDT identified few additional P. falciparum-positive patients as compared to co-RDT (276 vs 265 parasite-positive patients detected), with only a marginally greater sensitivity (75% vs 73%), using us-qPCR as the gold standard (357 parasite-positive patients detected). The specificity of both RDTs was >99%. Five of 11 additional patients testing positive by us-RDT had negative results by us-qPCR. The HRP2 concentration was above the limit of detection for co-RDT (>3653 pg of HRP2 per mL of blood) in almost all infections (99% [236 of 239]) with a parasite density >100 parasites per µL of blood. At parasite densities <100 parasites/µL, the HRP2 concentration was above the limits of detection of us-RDT (>793 pg/mL) and co-RDT in 29 (25%) and 24 (20%) of 118 patients, respectively.
CONCLUSION
There is neither an advantage nor a risk of using us-RDT, rather than co-RDT, for clinical malaria diagnosis. In febrile patients, only a small proportion of infections are characterized by a parasite density or an HRP2 concentration in the range where use of us-RDT would confer a meaningful advantage over co-RDT.

Identifiants

pubmed: 30476111
pii: 5205808
doi: 10.1093/infdis/jiy676
pmc: PMC6467194
doi:

Substances chimiques

Antigens, Protozoan 0
Biomarkers 0
HRP-2 antigen, Plasmodium falciparum 0
Protozoan Proteins 0
Reagent Kits, Diagnostic 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1490-1498

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Malar J. 2018 Mar 17;17(1):118
pubmed: 29549888
PLoS Med. 2015 Mar 03;12(3):e1001788
pubmed: 25734259
Lancet Infect Dis. 2018 Oct;18(10):1108-1116
pubmed: 30170986
Malar J. 2017 Mar 24;16(1):128
pubmed: 28340585
Nat Rev Microbiol. 2006 Sep;4(9 Suppl):S34-8
pubmed: 17034070
Stat Med. 1994 Nov 30;13(22):2345-58
pubmed: 7855468
Clin Vaccine Immunol. 2008 Jun;15(6):1012-8
pubmed: 18367583
Malar J. 2016 Oct 4;15(1):496
pubmed: 27716244
PLoS Med. 2017 Oct 23;14(10):e1002411
pubmed: 29059253
Malar J. 2012 Sep 13;11:325
pubmed: 22974086
Malar J. 2011 Apr 29;10:107
pubmed: 21529365
Malar J. 2012 Nov 16;11:377
pubmed: 23158019
Clin Infect Dis. 2010 Sep 1;51(5):506-11
pubmed: 20642354
Trans R Soc Trop Med Hyg. 2001 Mar-Apr;95(2):179-82
pubmed: 11355555
Am J Trop Med Hyg. 2017 Oct;97(4):1159-1162
pubmed: 28722629
Am J Trop Med Hyg. 2017 Nov;97(5):1540-1550
pubmed: 28820709
PLoS One. 2018 Jun 14;13(6):e0197982
pubmed: 29902174
Malar J. 2018 Jun 8;17(1):228
pubmed: 29884184
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents
pubmed: 19136431
J Clin Microbiol. 2018 Jul 26;56(8):
pubmed: 29898998
PLoS One. 2018 Aug 2;13(8):e0201769
pubmed: 30071004
J Infect Dis. 2018 Feb 14;217(5):685-692
pubmed: 29220497
J Infect Dis. 2009 Nov 15;200(10):1509-17
pubmed: 19848588
Am J Trop Med Hyg. 1997 May;56(5):538-47
pubmed: 9180605

Auteurs

Natalie E Hofmann (NE)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.

Clara Antunes Moniz (C)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.

Aurel Holzschuh (A)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.

Kristina Keitel (K)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.
Department of Pediatric Emergency Medicine, University Hospital Bern, Bern.

Noémie Boillat-Blanco (N)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.
Infectious Disease Service, University Hospital, Lausanne, Switzerland.
Ifakara Health Institute, Dar es Salaam, Tanzania.

Frank Kagoro (F)

Ifakara Health Institute, Dar es Salaam, Tanzania.

Josephine Samaka (J)

Amana Hospital, Dar es Salaam, Tanzania.

Zainab Mbarack (Z)

Mwananyamala Hospital, Dar es Salaam, Tanzania.

Xavier C Ding (XC)

FIND, Geneva, Switzerland.

Iveth J González (IJ)

FIND, Geneva, Switzerland.

Blaise Genton (B)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.
Infectious Disease Service, University Hospital, Lausanne, Switzerland.
Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.

Valérie D'Acremont (V)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.
Infectious Disease Service, University Hospital, Lausanne, Switzerland.
Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.

Ingrid Felger (I)

Swiss Tropical and Public Health Institute, Basel.
University of Basel, Basel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH